Skip to content

Kodiak Sciences Inc KOD Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

HRO
HarrowHROW
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
Ocular Therapeutix logo
Ocular TherapeutixOCUL
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's operating lease right-of-use assets in other assets?
Kodiak Sciences Inc (KOD) reported operating lease right-of-use assets in other assets of $34.38M in Q1 2026.
How has Kodiak Sciences Inc's operating lease right-of-use assets in other assets changed year-over-year?
Kodiak Sciences Inc's operating lease right-of-use assets in other assets decreased by 19.1% year-over-year, from $42.47M to $34.38M.
What is the long-term trend for Kodiak Sciences Inc's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's operating lease right-of-use assets in other assets has grown at a -13.1% compound annual growth rate (CAGR), from $73.67M to $36.61M.